Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 109380

In scope icon M 7 B
QID 109380 (Type "109380" in App Search)
A 32-year-old female is brought to the emergency department by her boyfriend for confusion. He reports that the patient had told him that she was staying home from work because of her allergies, which had been bothering her all week. When the patient’s boyfriend arrived home, he found the patient agitated and disoriented. He reports that when he tried to talk to her, she was "out of it" and kept asking for water. The boyfriend also reports that the patient recently received a negative evaluation at work and that she has been stressed. The patient’s past medical history is otherwise significant for ADHD, depression, and seasonal allergies. Her medications include amphetamine, desipramine, intranasal ipratropium, and diphenhydramine as needed. Her temperature is 102°F (38.9°C), blood pressure is 122/82 mmHg, pulse is 132/min, and respirations are 18/min with an oxygen saturation of 98% O2 on room air. Upon physical exam, the patient is agitated and grabbing at the air. She also appears flushed, her pupils are dilated, and she has scattered urticaria. The patient's EKG can be seen in Figure A. Which of the following is the most appropriate treatment for this patient?
  • A

Activated charcoal

4%

2/48

Atropine

2%

1/48

Physostigmine

42%

20/48

Pyridostigmine

15%

7/48

Sodium bicarbonate

33%

16/48

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient is presenting with fever, flushing, altered mental status, dry mouth, and mydriasis with increased exposure to an anticholinergic (e.g., ipratropium and diphenhydramine), suggesting the diagnosis of antichoinergic toxicity, which should be treated with physostigmine.

Anticholinergic toxicity can result from an overdose of a variety of medications, such as antihistamines, antimuscarinics (including inhaled agents and ophthalmic drops), scopolamine, tricyclic antidepressants (TCAs), anti-Parkinsons, and antipsychotics. Clinical features of anticholinergic intoxication include flushing, anhidrosis, blurred vision, hyperthermia, non-reactive mydriasis, alterations in mental status, delirium, hallucinations, constipation, urinary retention, urticaria, and tachycardia. The diagnosis of anticholinergic toxicity is based on these clinical findings and on the results of a trial of physostigmine, which is the initial management following stabilization of airway, breathing and circulation.

Figure A is an EKG demonstrating sinus tachycardia.

Incorrect Answers:
Answer 1: Activated charcoal can be used for gastrointestinal decontamination if an oral agent caused her toxicity, and if she presented within two hours of ingestion. In this case, her presentation is likely due to the overtreatment of her seasonal allergies with intranasal anticholinergic plus an antihistamine.

Answer 2: Atropine is a muscarinic antagonist that would worsen that patient’s anticholinergic toxicity symptoms. Atropine is instead used to block the effects of cholinesterase inhibitors, such as organophosphates. A cholinergic toxidrome would present with diarrhea, urination, miosis, bronchospasm, bradycardia, emesis, lacrimation, sweating, and salivation.

Answer 4: Pyridostigmine is an acetylcholinesterase inhibitor like physostigmine. However, unlike physostigmine, which is a tertiary amine, pyridostigmine is a quaternary amine, therefore it lacks the central antimuscarinic activity needed to make it an effective antidote. Pyridostigmine is used to treat myasthenia gravis.

Answer 5: Sodium bicarbonate should be given to protect against cardiotoxicity in TCA overdose. While this patient could have anticholinergic side effects from TCAs, her EKG does not show QRS prolongation or a ventricular arrhythmia, which would be indications for sodium bicarbonate. Other signs of TCA toxicity would be hypotension, convulsions, coma, and respiratory depression.

Bullet Summary:
Anticholinergic toxicity will present with a syndrome of anhidrosis, blurred vision, hyperthermia, constipation, urinary retention, and altered mental status, and it should be treated with physostigmine.

Authors
Rating
Please Rate Question Quality

4.4

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(9)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options